SCHEMBL5980971

SCHEMBL5980971

CCCCCCCCN(CCOc1ccc(CC(OCC)C(=O)O)cc1)C(=O)NCCCC

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 17/20 0.57
PPARG P37231 15/20 0.57
PPARD Q03181 5/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5976955 1.00 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL5977314 1.00 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL5979534 0.99 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL5977773 0.96 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL5978725 0.96 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL5979485 0.96 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL5977448 0.95 PPARA (0.58) PPARAPPARGPPARD
SCHEMBL5978490 0.94 PPARA (0.63) PPARAPPARGPPARD
SCHEMBL5978981 0.94 PPARA (0.54) PPARAPPARGPPARD
SCHEMBL5977377 0.94 PPARA (0.54) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7015345-B2 Propionic acid derivatives ASAHI KASEI PHARMA CORPORATION (JP) 2006-03-21 US disclosed
EP-1484316-A1 NOVEL PROPIONIC ACID DERIVATIVE Asahi Kasei Pharma Corporation (JP) 2004-12-08 EP disclosed
US-20040072690-A1 Novel propionic acid derivatives ASAHI KASEI PHARMA CORPORATION (JP) 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072690-A1 Novel propionic acid derivatives PNLIP, LIPC, GPR119 PPARA 37/4885PPARG 125/4885PPARD 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.